Tyra Biosciences: SURF302 Is A Worthwhile Binary Bet (NASDAQ:TYRA)
· seekingalpha.com
Tyra Biosciences' dabogratinib has an upcoming readout in September 2026 that I think could validate its FGFR3 profile. Read why TYRA stock is a Buy.
My name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, ...